share_log

HC Wainwright & Co. Initiates Coverage On Corvus Pharma With Buy Rating, Announces Price Target of $11

HC Wainwright & Co. Initiates Coverage On Corvus Pharma With Buy Rating, Announces Price Target of $11

HC Wainwright & Co. 開始對 Corvus Pharma 進行覆蓋,給予買入評級,宣佈目標價格爲 11 美元
Benzinga ·  01/02 04:00  · 評級/大行評級

HC Wainwright & Co. analyst Sean Lee initiates coverage on Corvus Pharma (NASDAQ:CRVS) with a Buy rating and announces Price Target of $11.

HC Wainwright & Co. 分析師Sean Lee 對Corvus Pharma (納斯達克:CRVS)啓動了覆蓋,給予買入評級,並宣佈目標價爲11美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論